Skip to main content
. 2022 Nov 27;14(11):1230–1249. doi: 10.4240/wjgs.v14.i11.1230

Figure 3.

Figure 3

Number of lymph nodes examined for each stage subgroup in the validation cohort. A: pT1; B: pT2; C: pT3; D: pT4. LNs: Lymph nodes.